Wordt geladen...
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis
BACKGROUND: The B cell chemoattractant CXCL13 is a promising biomarker in rheumatoid arthritis (RA), with a plausible role in supporting diagnosis, monitoring disease activity and as a prognostic value. It is a key chemokine driving the formation of lymphoid follicles within the inflamed synovium. T...
Bewaard in:
| Gepubliceerd in: | BMC Rheumatol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604968/ https://ncbi.nlm.nih.gov/pubmed/33292827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41927-020-00154-3 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|